Home » Pharmaceutical Articles » Dr. Mike Reed to Participate in Roundtable Panel of American Society of Phamacometrics
Dr. Mike Reed to Participate in Roundtable Panel of American Society of Phamacometrics
Industry presenters will focus on the Use and Benefits of Physiologic, Mechanistic Models in Drug Development
SAN CARLOS, CA, January 30, 2012 /Pharmaceutical PR News/ -- Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, today announced that Mike Reed, PhD, Vice President of Client Services, will participate in a roundtable panel to discuss " The Use of Physiological, Mechanistic Models in Drug Development and Therapy: Introduction, Case Studies, Impact, and Ideas for Applications". This is a local event sponsored by the American Society of Pharmacometrics (ASoP), to be held on Thursday, February 2, 2012, in Bridgewater, New Jersey. At this roundtable, industry experts will summarize the benefits and challenges in using physiological models for drug development, describe the modeling approaches used, report on program outcomes, and share ideas for the future of modeling. Registration for the event can be found at http://www.go-asop.org/physiological-models-NJ.
Rosa informs our customer's most critical decisions - from preclinical through clinical development - with the creation and use of mathematical models that simulate disease physiology, drug action, patient variability, and trial outcomes. To address the full spectrum of related issues, Rosa offers two customized approaches: classic pharmacokinetic/ pharmacodynamic (PK/PD) models and Rosa's innovative PhysioPD models. With these approaches, Rosa's clients collaborate in model creation and testing, retain the final model, and acquire the ability to use it and understand its implications for their drug development programs. Rosa's staff have close to two decades of unparalleled professional experience in using drug-disease modeling and simulation (M&S) to accelerate drug development; they have covered hundreds of applications with dozens of clients. The Rosa team is unique in their breadth and depth of disease area experience, which includes metabolic and cardiovascular diseases, oncology, gastro-intestinal disease, inflammatory diseases, immune dysfunction (including rheumatoid arthritis), pain, skin conditions, respiratory disorders, and antibacterials/antivirals. For more information, visit www.rosaandco.com.
---
Press release service and press release distribution provided by http://www.24-7pressrelease.com |
|
|
Press Release Contact Information:
Rebecca Baillie
Rosa & Co
Chief Scientist
751 Laurel St., Ste. 127
San Carlos, CA
USA 94070
Voice: 530-661-7476
Website: Visit Our Website |
|
|
|
|
| PHARMACEUTICAL ARCHIVE SEARCH |
|
|
| |
| SUBMIT PHARMACEUTICAL NEWS |
|
|
| |
|
|
Advertise With Us |
About Us |
Contact Us